These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15446314)

  • 1. Isometric tubular epithelial vacuolization in renal allograft biopsy specimens of patients receiving low-dose intravenous immunoglobulin for a positive crossmatch.
    Haas M; Sonnenday CJ; Cicone JS; Rabb H; Montgomery RA
    Transplantation; 2004 Aug; 78(4):549-56. PubMed ID: 15446314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isometric tubular vacuolization in renal transplant recipient: the first case report in Thailand.
    Ruangkanchanasetr P; Praechinavong W; Paueksakon P; Satirapoj B; Supasyndh O; Supaporn T
    J Med Assoc Thai; 2012 May; 95 Suppl 5():S168-71. PubMed ID: 22934464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of renal biopsies showing concurrent acute rejection and tacrolimus-associated tubular vacuolization.
    Randhawa PS; Saad RS; Jordan M; Scantlebury V; Vivas C; Shapiro R
    Transplantation; 1999 Jan; 67(1):85-9. PubMed ID: 9921801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative Desensitization Improves Outcomes Among Crossmatch Positive Recipients of Deceased Donor Renal Transplants.
    Sharma A; King A; Kumar D; Behnke M; McDougan F; Kimball PM
    Prog Transplant; 2016 Jun; 26(2):157-61. PubMed ID: 27207404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dosage intravenous immunoglobulin-associated macrovacuoles are associated with chronic tubulointerstitial lesion worsening in renal transplant recipients.
    Bollée G; Anglicheau D; Loupy A; Zuber J; Patey N; Mac Gregor D; Martinez F; Mamzer-Bruneel MF; Snanoudj R; Thervet E; Legendre C; Noël LH
    Clin J Am Soc Nephrol; 2008 Sep; 3(5):1461-8. PubMed ID: 18525007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A peculiar vacuolization in the kidney transplant of a child treated with tacrolimus.
    Watanabe S; Yamaguchi Y; Hattori M; Chikamoto H; Matsumoto N; Suzuki T; Oonishi M; Horita S; Tokumoto T; Tanabe K; Shiraga H; Toma H; Ito K
    Clin Transplant; 2000; 14 Suppl 3():30-2. PubMed ID: 11092350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a negative conversion trial and subsequent living donor kidney transplant outcome in recipients with a positive lymphocyte crossmatch.
    Huh KH; Kim SI; Joo DJ; Ju MK; Chang HK; Kim HJ; Kim YS; Kim MS
    Nephron Clin Pract; 2009; 111(1):c49-54. PubMed ID: 19052470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly Sensitized Patients: Miami Transplant Institute Experience.
    Mattiazzi AD; Centeno A; Amador A; Fernandez-Bango C; Scowby CD; O'Rourke M; Hill-Matthie T; Patel R; Barrios F; Ruiz P; Chen L; Saghesima J; Ciancio G; Burke GW; Goldstein M; Chandar J; Contreras G; Roth D; Kupin W; Guerra G; Vianna R
    Clin Transpl; 2014; ():171-8. PubMed ID: 26281142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine-needle aspiration cytology and conventional histology in 200 renal allografts.
    Reinholt FP; Bohman SO; Wilczek H; von Willebrand E; Häyry P
    Transplantation; 1990 May; 49(5):910-2. PubMed ID: 2336707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin induction therapy in renal transplant recipients: Effects on immunoglobulin and regulatory antibody levels.
    Staak A; Renner F; Suesal C; Dietrich H; Rainer L; Kamali-Ernst S; Ernst W; Padberg W; Opelz G; Weimer R
    Transplant Proc; 2006 Dec; 38(10):3483-5. PubMed ID: 17175311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of simultaneous kidney-pancreas transplantation with positive cross-match.
    Heilman RL; Chakkera H; Mazur M; Petrides S; Moss A; Mekeel K; Mulligan D; Reddy KS
    Transplant Proc; 2009; 41(1):303-6. PubMed ID: 19249540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience.
    Jin MK; Cho JH; Kwon O; Hong KD; Choi JY; Yoon SH; Park SH; Kim YL; Kim CD
    Transplant Proc; 2012 Jan; 44(1):200-3. PubMed ID: 22310614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desensitization and renal transplant: plasmapheresis/IVIG standard dose in patients with high immunological risk.
    Flores-Gama F; Mondragón-Ramírez GA; Bochicchio-Riccardelli T
    Cir Cir; 2009; 77(5):369-74. PubMed ID: 19944025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal safety of high-dose, sucrose-free intravenous immunoglobulin in kidney transplant recipients: an observational study.
    Luque Y; Anglicheau D; Rabant M; El Karoui K; Jamme M; Aubert O; Clément R; Noël LH; Bollée G; Brodin-Sartorius A; Martinie M; Kreis H; Timsit MO; Legendre C
    Transpl Int; 2016 Nov; 29(11):1205-1215. PubMed ID: 27529401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
    Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rescue treatment for cyclosporine-associated hemolytic-uremic syndrome with intravenous immunoglobulin.
    Wen YK; Chen ML
    Clin Nephrol; 2006 Jul; 66(1):58-62. PubMed ID: 16878437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of Total Lymphoid Irradiation, Low-Dose IVIG and ATG as Rescue Therapy for Highly Sensitized and Antibody-Mediated Rejection Renal Transplant Recipients.
    Zhu D; Qi G; Tang Q; Li L; Yang C; Lin M; Wu B; Xu M; Cai J; Zhu T; Rong R
    Clin Transpl; 2014; ():215-21. PubMed ID: 26281148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful rescue therapy with plasmapheresis and intravenous immunoglobulin for acute humoral renal transplant rejection.
    White NB; Greenstein SM; Cantafio AW; Schechner R; Glicklich D; McDonough P; Pullman J; Mohandas K; Boctor F; Uehlinger J; Tellis V
    Transplantation; 2004 Sep; 78(5):772-4. PubMed ID: 15371687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of cellular and humoral immunity in a successful case of positive crossmatch kidney transplantation: a case report.
    Tanimine N; Ide K; Yamashita M; Tanaka Y; Igarashi Y; Banshodani M; Tazawa H; Basnet NB; Doskali M; Onoe T; Tashiro H; Ohdan H
    Transplant Proc; 2011; 43(6):2411-4. PubMed ID: 21839279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.